Treating shock in young children with severe malnutrition and diarrhea
Part of Hormones & metabolism, Infections clinical trials.
This study tests a treatment approach to help children who are in “shock” (their body is struggling to maintain blood flow and oxygen) caused by diarrhea and severe undernutrition. It may help care teams stabilize children faster and improve outcomes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child is 1 to 59 months old and has diarrhea and acute malnutrition
- Your child has fluid-refractory shock (shock that is not improving with fluids alone)
- Your child has one of these conditions: cerebral palsy and/or developmental delay, or Down syndrome (with or without heart problems)
- A parent or caregiver can provide consent for the study
- Your child should not need breathing resuscitation (like CPR) during screening, and should not be gasping for air
- Your child’s blood should not be a rare blood type that is hard to match (if a matching donor is not available)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 3 study tests whether starting a blood-pressure medicine earlier in the emergency room can improve outcomes for people with low blood pressure or shock. It focuses on patients who have already received enough IV fluids and meet specific blood pressure and lab findings.
This study tests whether giving an intravenous medicine called methylene blue can help preterm infants with severe blood infection and shock who are not improving with standard treatments. It may reduce blood vessel problems and improve recovery.
This study compares two medicines, adrenaline and dopamine, to see which works better for children with septic shock (a serious infection causing very low blood pressure) that does not improve with fluids.
This study tests a new way to give fluids during sepsis in children to improve blood flow and recovery. It compares a standard saltwater solution to a plasma-based solution to see which works better.
This trial studies whether “blood pressure–supporting” medicines (given through a central line) work well and safely for adults in the ICU who have shock. Your team may use the results to improve care for people with low blood pressure and poor blood flow to organs.
This trial is testing a treatment approach for adults with cardiogenic shock, a life-threatening condition where the heart can’t pump enough blood. You may be considered if your shock started within the last 24 hours and you meet other safety criteria.
Hear when a new Blood Transfusion trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.